Troluce Capital Advisors »

Immunovant shares owned by Troluce Capital Advisors

Quarter-by-quarter ownership of Immunovant (IMVT) shares owned by Troluce Capital Advisors from 13F filings

Historical chart of Troluce Capital Advisors investment in Immunovant

Tip: Access up to 7 years of quarterly data

All positions including Immunovant held by Troluce Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunovant by Troluce Capital Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.2M 77k 28.51

More positions owned by Troluce Capital Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Endeavor Group Hldgs Cl A Com Put Option (EDR)
Tko Group Holdings Cl A (TKO)
Summit Matls Cl A Put Option (SUM)
Select Sector Spdr Tr Indl Put Option (XLI)
Smurfit Westrock SHS (SW)
Live Nation Entertainment Put Option (LYV)
Western Digital Call Option (WDC)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Flutter Entmt SHS Call Option (FLUT)
Vistra Energy Put Option (VST)
Siriusxm Holdings Common Stock Call Option (SIRI)
Select Sector Spdr Tr Sbi Materials Put Option (XLB)
Roivant Sciences SHS (ROIV)
Capri Holdings SHS (CPRI)

View all positions for Troluce Capital Advisors

Top funds holding Immunovant

FMR
Vanguard Group
BlackRock
Deep Track Capital
Armistice Capital
T. Rowe Price Investment Management
State Street Corporation
Perceptive Advisors
Viking Global Investors
Alpine Partners VI
Geode Capital Management
Woodline Partners
Paradigm Biocapital Advisors
Pictet Asset Management Holding SA
Baker Bros. Advisors

View all funds holding Immunovant